Role of proteolytic activation of protein kinase Cδ in the pathogenesis of prion disease

References

• Aguzzi A, Baumann F, Bremer J. The prion’s elusive reason for being. Annu Rev Neurosci 2008; 31:439 - 77; http://dx.doi.org/10.1146/annurev.neuro.31.060407.125620; PMID: 18558863
   PubMed Web of Science ®Google Scholar
• Martin DP, Anantharam V, Jin H, Witte T, Houk R, Kanthasamy A, Kanthasamy AG. Infectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease. Neurotoxicology 2011; 32:554 - 62; http://dx.doi.org/10.1016/j.neuro.2011.07.008; PMID: 21871919
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Molecular biology and pathogenesis of prion diseases. Trends Biochem Sci 1996; 21:482 - 7; http://dx.doi.org/10.1016/S0968-0004(96)10063-3; PMID: 9009832
   PubMed Web of Science ®Google Scholar
• Anantharam V, Kanthasamy A, Choi CJ, Martin DP, Latchoumycandane C, Richt JA, Kanthasamy AG. Opposing roles of prion protein in oxidative stress- and ER stress-induced apoptotic signaling. Free Radic Biol Med 2008; 45:1530 - 41; http://dx.doi.org/10.1016/j.freeradbiomed.2008.08.028; PMID: 18835352
   PubMed Web of Science ®Google Scholar
• Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, Jefferys JG. Prion protein is necessary for normal synaptic function. Nature 1994; 370:295 - 7; http://dx.doi.org/10.1038/370295a0; PMID: 8035877
   PubMed Web of Science ®Google Scholar
• Kanthasamy AG, Choi C, Jin H, Harischandra DS, Anantharam V, Kanthasamy A. Effect of divalent metals on the neuronal proteasomal system, prion protein ubiquitination and aggregation. Toxicol Lett 2012; 214:288 - 95; http://dx.doi.org/10.1016/j.toxlet.2012.09.008; PMID: 22995398
   PubMed Web of Science ®Google Scholar
• Choi CJ, Kanthasamy A, Anantharam V, Kanthasamy AG. Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases. Neurotoxicology 2006; 27:777 - 87; http://dx.doi.org/10.1016/j.neuro.2006.06.004; PMID: 16860868
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang SL, DeArmond SJ. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A 1993; 90:10608 - 12; http://dx.doi.org/10.1073/pnas.90.22.10608; PMID: 7902565
   PubMed Web of Science ®Google Scholar
• Guentchev M, Voigtländer T, Haberler C, Groschup MH, Budka H. Evidence for oxidative stress in experimental prion disease. Neurobiol Dis 2000; 7:270 - 3; http://dx.doi.org/10.1006/nbdi.2000.0290; PMID: 10964599
   PubMed Web of Science ®Google Scholar
• Kim JI, Choi SI, Kim NH, Jin JK, Choi EK, Carp RI, Kim YS. Oxidative stress and neurodegeneration in prion diseases. Ann N Y Acad Sci 2001; 928:182 - 6; http://dx.doi.org/10.1111/j.1749-6632.2001.tb05648.x; PMID: 11795509
   PubMed Web of Science ®Google Scholar
• Brown DR. Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence. Folia Neuropathol 2005; 43:229 - 43; PMID: 16416388
   PubMed Web of Science ®Google Scholar
• Kanthasamy A, Jin H, Mehrotra S, Mishra R, Kanthasamy A, Rana A. Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson’s disease. Neurotoxicology 2010; 31:555 - 61; http://dx.doi.org/10.1016/j.neuro.2009.12.003; PMID: 20005250
   PubMed Web of Science ®Google Scholar
• Kaul S, Anantharam V, Yang Y, Choi CJ, Kanthasamy A, Kanthasamy AG. Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells. J Biol Chem 2005; 280:28721 - 30; http://dx.doi.org/10.1074/jbc.M501092200; PMID: 15961393
   PubMed Web of Science ®Google Scholar
• Lin M, Chandramani-Shivalingappa P, Jin H, Ghosh A, Anantharam V, Ali S, Kanthasamy AG, Kanthasamy A. Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells. Neuroscience 2012; 210:308 - 32; http://dx.doi.org/10.1016/j.neuroscience.2012.03.004; PMID: 22445524
   PubMed Web of Science ®Google Scholar
• Saminathan H, Asaithambi A, Anantharam V, Kanthasamy AG, Kanthasamy A. Environmental neurotoxic pesticide dieldrin activates a non receptor tyrosine kinase to promote PKCδ-mediated dopaminergic apoptosis in a dopaminergic neuronal cell model. Neurotoxicology 2011; 32:567 - 77; http://dx.doi.org/10.1016/j.neuro.2011.06.009; PMID: 21801747
   PubMed Web of Science ®Google Scholar
• Mewes A, Franke H, Singer D. Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies. PLoS One 2012; 7:e45017; http://dx.doi.org/10.1371/journal.pone.0045017; PMID: 22984603
   PubMed Web of Science ®Google Scholar
• Cho S, Wood A, Bowlby MR. Brain slices as models for neurodegenerative disease and screening platforms to identify novel therapeutics. Curr Neuropharmacol 2007; 5:19 - 33; http://dx.doi.org/10.2174/157015907780077105; PMID: 18615151
   PubMed Web of Science ®Google Scholar
• Falsig J, Julius C, Margalith I, Schwarz P, Heppner FL, Aguzzi A. A versatile prion replication assay in organotypic brain slices. Nat Neurosci 2008; 11:109 - 17; http://dx.doi.org/10.1038/nn2028; PMID: 18066056
   PubMed Web of Science ®Google Scholar
• Falsig J, Sonati T, Herrmann US, Saban D, Li B, Arroyo K, Ballmer B, Liberski PP, Aguzzi A. Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures. PLoS Pathog 2012; 8:e1002985; http://dx.doi.org/10.1371/journal.ppat.1002985; PMID: 23133383
   PubMed Web of Science ®Google Scholar
• Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982; 218:1309 - 11; http://dx.doi.org/10.1126/science.6815801; PMID: 6815801
   PubMed Web of Science ®Google Scholar
• Polymenidou M, Moos R, Scott M, Sigurdson C, Shi YZ, Yajima B, Hafner-Bratkovic I, Jerala R, Hornemann S, Wuthrich K, et al. The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS One 2008; 3:e3872; http://dx.doi.org/10.1371/journal.pone.0003872; PMID: 19060956
   PubMed Web of Science ®Google Scholar
• Sigurdson CJ, Joshi-Barr S, Bett C, Winson O, Manco G, Schwarz P, Rülicke T, Nilsson KP, Margalith I, Raeber A, et al. Spongiform encephalopathy in transgenic mice expressing a point mutation in the β2-α2 loop of the prion protein. J Neurosci 2011; 31:13840 - 7; http://dx.doi.org/10.1523/JNEUROSCI.3504-11.2011; PMID: 21957246
   PubMed Web of Science ®Google Scholar
• Jin H, Kanthasamy A, Anantharam V, Rana A, Kanthasamy AG. Transcriptional regulation of pro-apoptotic protein kinase Cdelta: implications for oxidative stress-induced neuronal cell death. J Biol Chem 2011; 286:19840 - 59; http://dx.doi.org/10.1074/jbc.M110.203687; PMID: 21467032
   PubMed Web of Science ®Google Scholar
• Gordon R, Anantharam V, Kanthasamy AG, Kanthasamy A. Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation. J Neuroinflammation 2012; 9:82; http://dx.doi.org/10.1186/1742-2094-9-82; PMID: 22540228
   PubMed Web of Science ®Google Scholar
• Kanthasamy AG, Kitazawa M, Kaul S, Yang Y, Lahiri DK, Anantharam V, Kanthasamy A. Proteolytic activation of proapoptotic kinase PKCdelta is regulated by overexpression of Bcl-2: implications for oxidative stress and environmental factors in Parkinson’s disease. Ann N Y Acad Sci 2003; 1010:683 - 6; http://dx.doi.org/10.1196/annals.1299.125; PMID: 15033812
   PubMed Web of Science ®Google Scholar
• Pamplona R, Naudí A, Gavín R, Pastrana MA, Sajnani G, Ilieva EV, Del Río JA, Portero-Otín M, Ferrer I, Requena JR. Increased oxidation, glycoxidation, and lipoxidation of brain proteins in prion disease. Free Radic Biol Med 2008; 45:1159 - 66; http://dx.doi.org/10.1016/j.freeradbiomed.2008.07.009; PMID: 18703134
   PubMed Web of Science ®Google Scholar
• Freixes M, Rodríguez A, Dalfó E, Ferrer I. Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease. Neurobiol Aging 2006; 27:1807 - 15; http://dx.doi.org/10.1016/j.neurobiolaging.2005.10.006; PMID: 16310893
   PubMed Web of Science ®Google Scholar
• Yuan F, Yang L, Zhang Z, Wu W, Zhou X, Yin X, Zhao D. Cellular prion protein (PrPC) of the neuron cell transformed to a PK-resistant protein under oxidative stress, comprising main mitochondrial damage in prion diseases. J Mol Neurosci 2013; 51:219 - 24; http://dx.doi.org/10.1007/s12031-013-0008-6; PMID: 23715697
   PubMed Web of Science ®Google Scholar
• Jin H, Kanthasamy A, Ghosh A, Anantharam V, Kalyanaraman B, Kanthasamy AG. Mitochondria-targeted antioxidants for treatment of Parkinson’s disease: Preclinical and clinical outcomes. Biochim Biophys Acta 2013; http://dx.doi.org/10.1016/j.bbadis.2013.09.007; PMID: 24060637
   PubMed Web of Science ®Google Scholar
• Latchoumycandane C, Anantharam V, Jin H, Kanthasamy A, Kanthasamy A. Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson’s disease. Toxicol Appl Pharmacol 2011; 256:314 - 23; http://dx.doi.org/10.1016/j.taap.2011.07.021; PMID: 21846476
   PubMed Web of Science ®Google Scholar
• Li W, Mischak H, Yu JC, Wang LM, Mushinski JF, Heidaran MA, Pierce JH. Tyrosine phosphorylation of protein kinase C-delta in response to its activation. J Biol Chem 1994; 269:2349 - 52; PMID: 7507923
   PubMed Web of Science ®Google Scholar
• Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998; 281:2042 - 5; http://dx.doi.org/10.1126/science.281.5385.2042; PMID: 9748166
   PubMed Web of Science ®Google Scholar
• Yang Q, Hashizume Y, Yoshida M, Wang Y. Neuropathological study of cerebellar degeneration in prion disease. Neuropathology 1999; 19:33 - 9; http://dx.doi.org/10.1046/j.1440-1789.1999.00212.x; PMID: 19519645
   PubMed Web of Science ®Google Scholar
• Carimalo J, Cronier S, Petit G, Peyrin JM, Boukhtouche F, Arbez N, Lemaigre-Dubreuil Y, Brugg B, Miquel MC. Activation of the JNK-c-Jun pathway during the early phase of neuronal apoptosis induced by PrP106-126 and prion infection. Eur J Neurosci 2005; 21:2311 - 9; http://dx.doi.org/10.1111/j.1460-9568.2005.04080.x; PMID: 15932590
   PubMed Web of Science ®Google Scholar
• Bourteele S, Oesterle K, Weinzierl AO, Paxian S, Riemann M, Schmid RM, Planz O. Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein. Cell Microbiol 2007; 9:2202 - 17; http://dx.doi.org/10.1111/j.1462-5822.2007.00950.x; PMID: 17573907
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Heikenwalder M. Pathogenesis of prion diseases: current status and future outlook. Nat Rev Microbiol 2006; 4:765 - 75; http://dx.doi.org/10.1038/nrmicro1492; PMID: 16980938
   PubMed Web of Science ®Google Scholar
• Bessen RA, Robinson CJ, Seelig DM, Watschke CP, Lowe D, Shearin H, Martinka S, Babcock AM. Transmission of chronic wasting disease identifies a prion strain causing cachexia and heart infection in hamsters. PLoS One 2011; 6:e28026; http://dx.doi.org/10.1371/journal.pone.0028026; PMID: 22174765
   PubMedGoogle Scholar
• Castilla J, Morales R, Saá P, Barria M, Gambetti P, Soto C. Cell-free propagation of prion strains. EMBO J 2008; 27:2557 - 66; http://dx.doi.org/10.1038/emboj.2008.181; PMID: 18800058
   PubMed Web of Science ®Google Scholar
• Collins S, McLean CA, Masters CL. Gerstmann-Sträussler-Scheinker syndrome,fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci 2001; 8:387 - 97; http://dx.doi.org/10.1054/jocn.2001.0919; PMID: 11535002
   PubMed Web of Science ®Google Scholar
• O’Shea M, Maytham EG, Linehan JM, Brandner S, Collinge J, Lloyd SE. Investigation of mcp1 as a quantitative trait gene for prion disease incubation time in mouse. Genetics 2008; 180:559 - 66; http://dx.doi.org/10.1534/genetics.108.090894; PMID: 18716327
   PubMed Web of Science ®Google Scholar
• Zhang D, Anantharam V, Kanthasamy A, Kanthasamy AG. Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson’s disease. J Pharmacol Exp Ther 2007; 322:913 - 22; http://dx.doi.org/10.1124/jpet.107.124669; PMID: 17565007
   PubMed Web of Science ®Google Scholar
• Falsig J, Aguzzi A. The prion organotypic slice culture assay--POSCA. Nat Protoc 2008; 3:555 - 62; http://dx.doi.org/10.1038/nprot.2008.13; PMID: 18388937
   PubMed Web of Science ®Google Scholar
• Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V. Role of proteolytic activation of protein kinase Cdelta in oxidative stress-induced apoptosis. Antioxid Redox Signal 2003; 5:609 - 20; http://dx.doi.org/10.1089/152308603770310275; PMID: 14580317
   PubMed Web of Science ®Google Scholar
• Jin H, Kanthasamy A, Ghosh A, Yang Y, Anantharam V, Kanthasamy AG. α-Synuclein negatively regulates protein kinase Cδ expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity. J Neurosci 2011; 31:2035 - 51; http://dx.doi.org/10.1523/JNEUROSCI.5634-10.2011; PMID: 21307242
   PubMed Web of Science ®Google Scholar
• Sinclair L, Lewis V, Collins SJ, Haigh CL. Cytosolic caspases mediate mislocalised SOD2 depletion in an in vitro model of chronic prion infection. Dis Model Mech 2013; 6:952 - 63; http://dx.doi.org/10.1242/dmm.010678; PMID: 23580200
   PubMed Web of Science ®Google Scholar
• Sonati T, Reimann RR, Falsig J, Baral PK, O’Connor T, Hornemann S, Yaganoglu S, Li B, Herrmann US, Wieland B, et al. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature 2013; 501:102 - 6; http://dx.doi.org/10.1038/nature12402; PMID: 23903654
   PubMed Web of Science ®Google Scholar
• Kikkawa U, Matsuzaki H, Yamamoto T. Protein kinase C delta (PKC delta): activation mechanisms and functions. J Biochem 2002; 132:831 - 9; http://dx.doi.org/10.1093/oxfordjournals.jbchem.a003294; PMID: 12473183
   PubMed Web of Science ®Google Scholar
• Anantharam V, Kitazawa M, Wagner J, Kaul S, Kanthasamy AG. Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J Neurosci 2002; 22:1738 - 51; PMID: 11880503
   PubMed Web of Science ®Google Scholar
• Kitazawa M, Anantharam V, Kanthasamy AG. Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration. Neuroscience 2003; 119:945 - 64; http://dx.doi.org/10.1016/S0306-4522(03)00226-4; PMID: 12831855
   PubMed Web of Science ®Google Scholar
• Reyland ME. Protein kinase Cdelta and apoptosis. Biochem Soc Trans 2007; 35:1001 - 4; http://dx.doi.org/10.1042/BST0351001; PMID: 17956263
   PubMed Web of Science ®Google Scholar
• Yun SW, Gerlach M, Riederer P, Klein MA. Oxidative stress in the brain at early preclinical stages of mouse scrapie. Exp Neurol 2006; 201:90 - 8; http://dx.doi.org/10.1016/j.expneurol.2006.03.025; PMID: 16806186
   PubMed Web of Science ®Google Scholar
• Merchenthaler I, Liposits Z, Reid JJ, Wetsel WC. Light and electron microscopic immunocytochemical localization of PKC delta immunoreactivity in the rat central nervous system. J Comp Neurol 1993; 336:378 - 99; http://dx.doi.org/10.1002/cne.903360306; PMID: 8263228
   PubMed Web of Science ®Google Scholar
• Barmack NH, Qian Z, Yoshimura J. Regional and cellular distribution of protein kinase C in rat cerebellar Purkinje cells. J Comp Neurol 2000; 427:235 - 54; http://dx.doi.org/10.1002/1096-9861(20001113)427:2<235::AID-CNE6>3.0.CO;2-6; PMID: 11054691
   PubMed Web of Science ®Google Scholar
• Cooper SA, Murray KL, Heath CA, Will RG, Knight RS. Sporadic Creutzfeldt-Jakob disease with cerebellar ataxia at onset in the UK. J Neurol Neurosurg Psychiatry 2006; 77:1273 - 5; http://dx.doi.org/10.1136/jnnp.2006.088930; PMID: 16835290
   PubMed Web of Science ®Google Scholar
• Glatzel M, Stoeck K, Seeger H, Lührs T, Aguzzi A. Human prion diseases: molecular and clinical aspects. Arch Neurol 2005; 62:545 - 52; http://dx.doi.org/10.1001/archneur.62.4.545; PMID: 15824251
   PubMed Web of Science ®Google Scholar
• Deacon RM. Measuring the strength of mice. J Vis Exp 2013; PMID: 23770643
   PubMedGoogle Scholar
• Chou AH, Yeh TH, Ouyang P, Chen YL, Chen SY, Wang HL. Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiol Dis 2008; 31:89 - 101; http://dx.doi.org/10.1016/j.nbd.2008.03.011; PMID: 18502140
   PubMed Web of Science ®Google Scholar
• Guyenet SJ, Furrer SA, Damian VM, Baughan TD, La Spada AR, Garden GA. A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J Vis Exp 2010; http://dx.doi.org/10.3791/1787; PMID: 20495529
   PubMedGoogle Scholar
• Ghosh A, Saminathan H, Kanthasamy A, Anantharam V, Jin H, Sondarva G, Harischandra DS, Qian Z, Rana A, Kanthasamy AG. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease. J Biol Chem 2013; 288:21955 - 71; http://dx.doi.org/10.1074/jbc.M112.444224; PMID: 23754278
   PubMed Web of Science ®Google Scholar
• Kanthasamy AG, Anantharam V, Zhang D, Latchoumycandane C, Jin H, Kaul S, Kanthasamy A. A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson’s disease models. Free Radic Biol Med 2006; 41:1578 - 89; http://dx.doi.org/10.1016/j.freeradbiomed.2006.08.016; PMID: 17045926
   PubMed Web of Science ®Google Scholar
• Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, Tsukiyama T, Nagahama H, Ohno S, Hatakeyama S, et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 2002; 416:865 - 9; http://dx.doi.org/10.1038/416865a; PMID: 11976687
   PubMed Web of Science ®Google Scholar
• Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, Brandner S, Jefferys JG, Collinge J. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007; 53:325 - 35; http://dx.doi.org/10.1016/j.neuron.2007.01.005; PMID: 17270731
   PubMed Web of Science ®Google Scholar
• Guenther K, Deacon RM, Perry VH, Rawlins JN. Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur J Neurosci 2001; 14:401 - 9; http://dx.doi.org/10.1046/j.0953-816x.2001.01645.x; PMID: 11553290
   PubMed Web of Science ®Google Scholar